ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

TRDA Entrada Therapeutics Inc

13,16
-0,40 (-2,95%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Entrada Therapeutics Inc TRDA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,40 -2,95% 13,16 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
13,70 12,92 13,91 13,16 13,56
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.3.202412:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
08.3.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
06.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
06.3.202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202413:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
03.1.202413:16EDGAR2Form 8-K - Current report
03.1.202413:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
26.12.202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:26EDGAR2Form 144 - Report of proposed sale of securities
06.12.202313:00EDGAR2Form 8-K - Current report
22.11.202317:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
22.11.202313:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
22.11.202313:35EDGAR2Form 8-K - Current report
22.11.202313:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
07.11.202313:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:08EDGAR2Form 8-K - Current report
07.11.202313:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
01.11.202312:01EDGAR2Form 8-K - Current report
12.10.202313:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
29.9.202322:39EDGAR2Form 8-K - Current report
29.9.202322:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21.9.202313:09EDGAR2Form 8-K - Current report
21.9.202313:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
07.9.202313:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
06.9.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202322:09EDGAR2Form 144 - Report of proposed sale of securities
06.9.202322:09EDGAR2Form 144 - Report of proposed sale of securities
06.9.202322:08EDGAR2Form 144 - Report of proposed sale of securities
05.9.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
29.8.202313:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
10.8.202313:09EDGAR2Form 8-K - Current report
10.8.202313:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
08.8.202313:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
08.8.202313:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
08.8.202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202313:07EDGAR2Form 8-K - Current report
08.8.202313:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
04.8.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:10EDGAR2Form 144 - Report of proposed sale of securities
01.8.202313:08EDGAR2Form 8-K - Current report
01.8.202313:00GLOBEEntrada Therapeutics Receives Authorization in the United..
12.7.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock